221 related articles for article (PubMed ID: 20801771)
1. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.
Turner D; Leach ST; Mack D; Uusoue K; McLernon R; Hyams J; Leleiko N; Walters TD; Crandall W; Markowitz J; Otley AR; Griffiths AM; Day AS
Gut; 2010 Sep; 59(9):1207-12. PubMed ID: 20801771
[TBL] [Abstract][Full Text] [Related]
2. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response.
Turner D; Mack D; Leleiko N; Walters TD; Uusoue K; Leach ST; Day AS; Crandall W; Silverberg MS; Markowitz J; Otley AR; Keljo D; Mamula P; Kugathasan S; Hyams J; Griffiths AM
Gastroenterology; 2010 Jun; 138(7):2282-91. PubMed ID: 20193683
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
4. Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation.
Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Ciclitira PJ; Sherwood RA; Nicholls JR
Eur J Gastroenterol Hepatol; 2009 May; 21(5):544-50. PubMed ID: 19300275
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
[TBL] [Abstract][Full Text] [Related]
6. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
Joshi S; Lewis SJ; Creanor S; Ayling RM
Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
[TBL] [Abstract][Full Text] [Related]
7. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.
Turner D; Otley AR; Mack D; Hyams J; de Bruijne J; Uusoue K; Walters TD; Zachos M; Mamula P; Beaton DE; Steinhart AH; Griffiths AM
Gastroenterology; 2007 Aug; 133(2):423-32. PubMed ID: 17681163
[TBL] [Abstract][Full Text] [Related]
8. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.
Turner D; Seow CH; Greenberg GR; Griffiths AM; Silverberg MS; Steinhart AH
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010
[TBL] [Abstract][Full Text] [Related]
9. Faecal markers of gastrointestinal inflammation.
Sherwood RA
J Clin Pathol; 2012 Nov; 65(11):981-5. PubMed ID: 22813730
[TBL] [Abstract][Full Text] [Related]
10. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
12. Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach.
Turner D; Griffiths AM; Steinhart AH; Otley AR; Beaton DE
J Clin Epidemiol; 2009 Jul; 62(7):738-44. PubMed ID: 19124220
[TBL] [Abstract][Full Text] [Related]
13. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
[TBL] [Abstract][Full Text] [Related]
14. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
[TBL] [Abstract][Full Text] [Related]
15. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis.
Schechter A; Griffiths C; Gana JC; Shaoul R; Shamir R; Shteyer E; Bdolah-Abram T; Ledder O; Turner D
Gut; 2015 Apr; 64(4):580-8. PubMed ID: 24848266
[TBL] [Abstract][Full Text] [Related]
16. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.
Roszak D; Gałęcka M; Cichy W; Szachta P
Adv Med Sci; 2015 Sep; 60(2):246-52. PubMed ID: 25989184
[TBL] [Abstract][Full Text] [Related]
17. [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis].
Xiang JY; Ouyang Q; Li GD
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2262-4. PubMed ID: 18001547
[TBL] [Abstract][Full Text] [Related]
18. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
van Rheenen PF
Inflamm Bowel Dis; 2012 Nov; 18(11):2018-25. PubMed ID: 22275341
[TBL] [Abstract][Full Text] [Related]
19. Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis.
Frin AC; Filippi J; Boschetti G; Flourie B; Drai J; Ferrari P; Hebuterne X; Nancey S
Dig Liver Dis; 2017 Jan; 49(1):11-16. PubMed ID: 27693318
[TBL] [Abstract][Full Text] [Related]
20. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
